Your browser doesn't support javascript.
loading
Plasma Hemoglobin and Red Blood Cell Mass Levels as Dynamic Prognostic Markers for Progression and Survival in Pancreatic Neuroendocrine Tumors.
Halperin, Reut; Ahron-Hananel, Genya; Badarna, Muhamad; Greidinger, Dahlia; Uri, Inbal; Percik, Ruth; Tirosh, Amit.
Afiliação
  • Halperin R; Sheba Medical Center at Tel Hashomer, Endocrinology, Diabetes and Metabolism Center, Tel Hashomer, Israel.
  • Ahron-Hananel G; Sheba Medical Center at Tel Hashomer, Neuroendocrine Tumors Service, Tel Hashomer, Israel.
  • Badarna M; Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv, Israel.
  • Greidinger D; Sheba Medical Center at Tel Hashomer, Endocrinology, Diabetes and Metabolism Center, Tel Hashomer, Israel.
  • Uri I; Sheba Medical Center at Tel Hashomer, Endocrinology, Diabetes and Metabolism Center, Tel Hashomer, Israel.
  • Percik R; Sheba Medical Center at Tel Hashomer, Internal Medicine, Tel Hashomer, Israel.
  • Tirosh A; Sheba Medical Center at Tel Hashomer, Endo-Oncology Clinic, Tel Hashomer, Israel.
Horm Metab Res ; 53(12): 810-817, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34891211
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Hemoglobinas / Tumores Neuroendócrinos / Volume de Eritrócitos Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Hemoglobinas / Tumores Neuroendócrinos / Volume de Eritrócitos Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel